Baohui Han

机构：Shanghai Chest Hospital

发表论文 10 篇 · 总被引 63 次 · h-index 6

代表论文

• The expression of stem cell‐related indicators as a prognostic factor in human lung adenocarcinoma (2010 · Journal of Surgical Oncology · 被引 21)
• [Establishment of a predicting model to evaluate the probability of malignancy or benign in patients with solid solitary pulmonary nodules]. (2016 · PubMed · 被引 11)
• CAMPASS: Benmelstobart in combination with anlotinib vs pembrolizumab in the first-line treatment of advanced non-small cell lung cancer (aNSCLC)—A randomized, single-blind, multicenter phase 3 study. (2025 · Journal of Clinical Oncology · 被引 8)
• [Evaluation on effect of feiji recipe on quality of life of patients with non-small cell lung cancer by adopting international questionnaire of QOL]. (2006 · PubMed · 被引 8)
• Efficacy, safety, and prognostic factors of anlotinib treatment in advanced non-small cell lung cancer patients (2022 · Journal of Cancer Research and Therapeutics · 被引 7)
• The evaluation of efficacy and safety of sunitinib on EGFR‐TKI pretreated advanced non‐small cell lung cancer patients in C hina (2013 · The Clinical Respiratory Journal · 被引 7)